KEVIN GAREY to Fluoroquinolones
This is a "connection" page, showing publications KEVIN GAREY has written about Fluoroquinolones.
Connection Strength
1.668
-
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk. J Infect Dis. 2025 Dec 20; 232(6):1446-1456.
Score: 0.893
-
Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother. 2017 06; 61(6).
Score: 0.493
-
Trovafloxacin: an overview. Pharmacotherapy. 1999 Jan; 19(1):21-34.
Score: 0.138
-
Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone. Pharm World Sci. 2005 Apr; 27(2):81-2.
Score: 0.053
-
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. Nat Commun. 2023 07 12; 14(1):4130.
Score: 0.047
-
Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. Diagn Microbiol Infect Dis. 2002 Sep; 44(1):59-61.
Score: 0.044